INS and Hepatic steatosis: Likewise, a Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) study found that rosiglitazone treatment for one year could improve hepatic steatosis and insulin sensitivity, but not liver inflammation and fibrosis [192].